Structure

InChI Key DMKSVUSAATWOCU-HROMYWEYSA-N
Smile CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
InChI
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H31ClO7
Molecular Weight 466.96
AlogP 3.92
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 99.13
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 32.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Glucocorticoid receptor agonist PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Cataract 3 D002386 ClinicalTrials
Blepharitis 2 D001762 ClinicalTrials
Eye Pain 1 D058447 ClinicalTrials

Related Entries

Scaffolds

Parent
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Eye disorders
39.92
Injury, poisoning and procedural complications
15.09
General disorders and administration site conditions
10.29
Nervous system disorders
9.4
Skin and subcutaneous tissue disorders
5.05
Immune system disorders
3.02
Respiratory, thoracic and mediastinal disorders
2.56
Investigations
2.24
Product issues
2.13

Cross References

Resources Reference
CAS NUMBER 82034-46-6
ChEBI 31784
ChEMBL CHEMBL1200865
DrugBank DB14596
DrugCentral 1611
EPA CompTox DTXSID2046468
FDA SRS YEH1EZ96K6
Guide to Pharmacology 7085
PharmGKB PA164764569
PubChem 444025
SureChEMBL SCHEMBL23907
ZINC ZINC000003920673